Driving Impairment Cases Involving Flualprazolam.
J Anal Toxicol
; 46(7): e191-e195, 2022 Aug 13.
Article
in English
| MEDLINE | ID: covidwho-2001341
ABSTRACT
Flualprazolam is a novel psychoactive substance in the benzodiazepine class that is increasing in prevalence in the USA. This study describes 19 cases of drivers stopped for impaired driving where flualprazolam was detected. This represents â¼9% of the total cases submitted to the Sedgwick County Regional Forensic Science Center toxicology laboratory between July 2019 and May 2020. Blood concentrations of flualprazolam ranged from 4 to 69 ng/mL, with mean and median concentrations of 20.9 ng/mL and 15 ng/mL, respectively. The increased prevalence in which laboratories are detecting flualprazolam along with the low concentrations necessary for pharmacological effects illustrates the importance of laboratories to remain vigilant in testing for novel psychoactive substances.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Automobile Driving
/
Substance Abuse Detection
Type of study:
Diagnostic study
/
Observational study
Language:
English
Journal:
J Anal Toxicol
Year:
2022
Document Type:
Article
Affiliation country:
Jat
Similar
MEDLINE
...
LILACS
LIS